Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000352755 | SCV000341385 | uncertain significance | not provided | 2016-05-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000535460 | SCV000634650 | uncertain significance | Familial aplasia of the vermis; Meckel-Gruber syndrome; Nephronophthisis | 2022-06-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 1276 of the CEP290 protein (p.Gly1276Arg). This variant is present in population databases (rs267603712, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with CEP290-related conditions. ClinVar contains an entry for this variant (Variation ID: 79258). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002483119 | SCV002775247 | uncertain significance | Leber congenital amaurosis 10; Meckel syndrome, type 4; Senior-Loken syndrome 6; Joubert syndrome 5; Bardet-Biedl syndrome 14 | 2022-01-14 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001271577 | SCV001452843 | uncertain significance | Leber congenital amaurosis | 2020-09-16 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004542738 | SCV004794947 | uncertain significance | CEP290-related disorder | 2024-09-23 | no assertion criteria provided | clinical testing | The CEP290 c.3826G>A variant is predicted to result in the amino acid substitution p.Gly1276Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0065% of alleles in individuals of African descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |